Tetrachlorodecaoxide (TCDO) is a chlorite containing drug used for the dressing of wounds immunomodulation and as radiation protective agent. It is the active principle of the drug Oxoferin made by Brookes Pharmaceutical Laboratories (Pakistan) Ltd under license from Oxo Chemie GmbH. In May 2002 Oxo Chemie was acquired by Dimethaid Research Inc (now Nuvo Research Inc).
This page contains content from the copyrighted Wikipedia article "Tetrachlorodecaoxide"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.
